A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn


Contact us at to request profile updates/corrections. You must be an official company representative to do so (only requests from corporate emails are accepted).

Cloud Pharmaceuticals


Cloud Pharmaceuticals delivers novel molecular designs of ligands to your druggable targets using our Quantum Molecular Design process deployed on cloud-based high performance computing platforms. The process is run by Cloud Pharmaceuticals' experts in a high-throughput production environment and has three components:

- An artificial Intelligence search of virtual chemical space
- Highly accurate binding affinity prediction
- Chemical property filters for drug-like properties, safety, and synthesizability

Year Founded
United States of America based
$1.347 M
Field/area focus
Research papers
Research Use Case
  • Lead Identification
  • Lead optimization
  • Preclinical Experiments
Business model
  • platform licensing
  • drug candidate-as-a-service
Data type
  • chemical notations
Drug Discovery Strategy
  • Target-based drug discovery (TDD)
Product type
  • small molecules

Industry Partnerships

2018GSKCloud will use its proprietary AI-driven process to design the molecules.

Posts Mentioning This Company

[Interview] Adoption of AI-driven Tools By The Life Sciences Professionals: What Is Coming In 2018? - Jan. 18, 2018
Biopharma Insights